CIK 0001582554
- Non-accelerated filer
- Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463011414
- Phone
- +1 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-15 | Matkovits Theresa Chief Development Officer | Grant or award · Stock Option (right to Buy) | +1,300,000 | 1,300,000 | ||
| 2022-12-20 | Matkovits Theresa Chief Development Officer | Grant or award · Stock Option (right to Buy) | +625,000 | 625,000 | ||
| 2021-12-14 | Matkovits Theresa Chief Development Officer | Grant or award · Stock Option (right to Buy) | +500,000 | 500,000 | ||
| 2021-01-01 | Matkovits Theresa Chief Development Officer | Grant or award · Stock option (right to buy) | +425,000 | 425,000 | ||
| 2020-06-17 | Matkovits Theresa Chief Development Officer | Grant or award · Stock option (right to buy) | +175,000 | 175,000 | ||
| 2020-01-01 | Matkovits Theresa Chief Development Officer | Grant or award · Stock option (right to buy) | +350,000 | 350,000 | ||
| 2019-02-11 | Matkovits Theresa Chief Development Officer | Grant or award · Option (right to buy) | +350,000 | 350,000 | ||
| 2018-10-15 | Matkovits Theresa Chief Development Officer | Grant or award · Option (right to buy) | +350,000 | 350,000 |
Page 1 of 1 · 8 trades